Total Knee Arthroplasty in Human Immunodeficiency Virus Patients: A Literature Review.

Human immunodeficiency virus (HIV) Knee osteonecrosis (ON) Outcomes Total knee arthroplasty (TKA)

Journal

Arthroplasty today
ISSN: 2352-3441
Titre abrégé: Arthroplast Today
Pays: United States
ID NLM: 101681808

Informations de publication

Date de publication:
Jun 2024
Historique:
received: 10 02 2024
revised: 28 02 2024
accepted: 19 03 2024
medline: 14 6 2024
pubmed: 14 6 2024
entrez: 14 6 2024
Statut: epublish

Résumé

Total knee arthroplasty (TKA) has become a common surgical intervention for human immunodeficiency virus (HIV)-positive patients who develop osteonecrosis of the knee. This paper summarized existing literature regarding the outcomes of HIV-positive patients undergoing TKA in 4 subsections: (1) complications; (2) survivorship analyses; (3) patient-reported outcomes; and (4) infections. A review of PubMed was performed, searching for articles focused on HIV-positive patients undergoing TKA. There were 6 reports selected, containing 4765 HIV-positive patients, and data regarding the various domains was tabulated and analyzed. To ensure article quality, a methodology score and level of evidence were determined for selected studies. Complication rates for HIV-positive patients were low, with a larger study reporting that 7.8% of HIV-positive patients developed a complication in comparison to 8% of HIV-negative patients. Survivorship analyses showed similar results, with a study reporting implant survivorship of 98% for HIV-positive and 99% for HIV-negative patients. There were no differences in patient-reported outcomes; HIV-positive patients improved from baseline with respect to the mean Knee Society objective and mean Knee Society functional scores, and the University of California, Los Angeles self-reported activity levels. The infection rate for HIV-positive patients was low, with a larger database study reporting that 0.6% of HIV-positive patients developed a wound infection in comparison to 0.4% of HIV-negative patients. A TKA is an effective treatment for HIV-positive patients who develop osteonecrosis of the knee. Results showed similar patient-reported outcomes, implant survivorships, revisions, and complication rates when compared to non-HIV patients.

Sections du résumé

Background UNASSIGNED
Total knee arthroplasty (TKA) has become a common surgical intervention for human immunodeficiency virus (HIV)-positive patients who develop osteonecrosis of the knee. This paper summarized existing literature regarding the outcomes of HIV-positive patients undergoing TKA in 4 subsections: (1) complications; (2) survivorship analyses; (3) patient-reported outcomes; and (4) infections.
Methods UNASSIGNED
A review of PubMed was performed, searching for articles focused on HIV-positive patients undergoing TKA. There were 6 reports selected, containing 4765 HIV-positive patients, and data regarding the various domains was tabulated and analyzed. To ensure article quality, a methodology score and level of evidence were determined for selected studies.
Results UNASSIGNED
Complication rates for HIV-positive patients were low, with a larger study reporting that 7.8% of HIV-positive patients developed a complication in comparison to 8% of HIV-negative patients. Survivorship analyses showed similar results, with a study reporting implant survivorship of 98% for HIV-positive and 99% for HIV-negative patients. There were no differences in patient-reported outcomes; HIV-positive patients improved from baseline with respect to the mean Knee Society objective and mean Knee Society functional scores, and the University of California, Los Angeles self-reported activity levels. The infection rate for HIV-positive patients was low, with a larger database study reporting that 0.6% of HIV-positive patients developed a wound infection in comparison to 0.4% of HIV-negative patients.
Conclusions UNASSIGNED
A TKA is an effective treatment for HIV-positive patients who develop osteonecrosis of the knee. Results showed similar patient-reported outcomes, implant survivorships, revisions, and complication rates when compared to non-HIV patients.

Identifiants

pubmed: 38872811
doi: 10.1016/j.artd.2024.101382
pii: S2352-3441(24)00067-0
pmc: PMC11170345
doi:

Types de publication

Journal Article

Langues

eng

Pagination

101382

Informations de copyright

© 2024 The Authors.

Auteurs

Asaf Miller (A)

University of Maryland, College Park, MD.

Daniel Hameed (D)

Rubin Institute for Advanced Orthopedics, LifeBridge Health, Sinai Hospital of Baltimore, Baltimore, MD.

Jeremy Dubin (J)

Rubin Institute for Advanced Orthopedics, LifeBridge Health, Sinai Hospital of Baltimore, Baltimore, MD.

Michael A Mont (MA)

Rubin Institute for Advanced Orthopedics, LifeBridge Health, Sinai Hospital of Baltimore, Baltimore, MD.

Deepak V Patel (DV)

Clinical Orthopaedic Surgery, Seton Hall University School of Graduate Medical Education, South Orange, NJ, USA.
Orthopaedic Surgery Residency, Translational Research and Education Program, St. Joseph's University Hospital and Regional Medical Center, Paterson, NJ, USA.

Christopher Bibbo (C)

Rubin Institute for Advanced Orthopedics Sinai Hospital of Baltimore, Head of Foot and Ankle Surgery, Foot and Ankle Deformity Correction, International Center for Limb Lengthening, Baltimore, MD, USA.

Ian S Hong (IS)

Division of Orthopaedic Trauma & Adult Reconstruction, Department of Orthopaedic Surgery, Cooperman Barnabas Medical Center/Jersey City Medical Center, RWJ Barnabas Health, Jersey City, NJ, USA.

Classifications MeSH